GW Henssler & Associates’s Axcelis ACLS Stock Holding History

GW Henssler & Associates’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,234	Closed	-$201K	–	161
2023 Q3	$201K	Buy	+1,234	New	+$217K	0.01%	194

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GW Henssler & Associates's ACLS Position: Q4 2023 in Review

GW Henssler & Associates sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 1,234 shares — an estimated $201K sold.

GW Henssler & Associates first reported a position in ACLS in Q3 2023 and held it in 1 quarter. The position peaked at $201K in Q3 2023. 421 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

GW Henssler & Associates reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
GW Henssler & Associates sold 1,234 Axcelis shares in Q4 2023, an estimated $201K.
GW Henssler & Associates first reported a position in Axcelis in Q3 2023 and held it in 1 quarter.
GW Henssler & Associates's Axcelis position peaked at $201K in Q3 2023.
421 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on GW Henssler & Associates's 13F filing for Q4 2023, filed 26 Jan 2024.